Alx Oncology Holdings, Inc. (ALXO) has disclosed a new risk, in the Share Price & Shareholder Rights category.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Alx Oncology Holdings, Inc. faces a significant risk due to its potential delisting from the Nasdaq Global Select Market, which could adversely affect its stock liquidity and price. The company has been notified by Nasdaq of non-compliance with the minimum bid price requirement, as its stock has closed below $1.00 per share for over 30 consecutive business days. This situation threatens Alx Oncology’s ability to raise additional funds and maintain investor confidence. If the company fails to regain compliance within the given 180-day period, it may face further financial challenges and diminished market presence.
Overall, Wall Street has a Strong Buy consensus rating on ALXO stock based on 3 Buys and 1 Hold.
To learn more about Alx Oncology Holdings, Inc.’s risk factors, click here.